Apomorphine inhalation (Alexza Pharmaceuticals)

N/A

Report date: 2024/03/07 13:13:11

Base Information

Drug NameApomorphine inhalation (Alexza Pharmaceuticals)

Drug Alias NameApomorphine cartridge (Alexza Pharmaceuticals)Staccato cartridge (Alexza Pharmaceuticals）Staccato® ApomorphineAZ-009 (Alexza Pharmaceuticals)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionDopamine receptors agonists

TargetsDopamine receptors

Therapy Area/IndicationsParkinson Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAlexza Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAlexza Pharmaceuticals Inc

Active IndicationsN/A

Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A